Observational studyBMC urology2022

Pre- and intratherapeutic predictors of overall survival in patients with advanced metastasized castration-resistant prostate cancer receiving Lu-177-PSMA-617 radioligand therapy.

Robin Wrenger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.